264 related articles for article (PubMed ID: 23047841)
21. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
[TBL] [Abstract][Full Text] [Related]
22. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling.
Hornsby CD; Cohen C; Amin MB; Picken MM; Lawson D; Yin-Goen Q; Young AN
Arch Pathol Lab Med; 2007 Oct; 131(10):1541-6. PubMed ID: 17922590
[TBL] [Abstract][Full Text] [Related]
23. Differentiation between fat-poor angiomyolipoma and clear cell renal cell carcinoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.
Ye J; Xu Q; Wang SA; Zheng J; Zhu QQ; Dou WQ
Abdom Radiol (NY); 2020 Feb; 45(2):512-519. PubMed ID: 31705246
[TBL] [Abstract][Full Text] [Related]
24. Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.
Gentili F; Bronico I; Maestroni U; Ziglioli F; Silini EM; Buti S; de Filippo M
Radiol Med; 2020 Dec; 125(12):1280-1287. PubMed ID: 32385827
[TBL] [Abstract][Full Text] [Related]
25. Arterial spin labeling MR imaging for characterisation of renal masses in patients with impaired renal function: initial experience.
Pedrosa I; Rafatzand K; Robson P; Wagner AA; Atkins MB; Rofsky NM; Alsop DC
Eur Radiol; 2012 Feb; 22(2):484-92. PubMed ID: 21877173
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma.
Adley BP; Papavero V; Sugimura J; Teh BT; Yang XJ
Anal Quant Cytol Histol; 2006 Aug; 28(4):228-36. PubMed ID: 16927643
[TBL] [Abstract][Full Text] [Related]
27. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma.
Choi YD; Kim KS; Ryu S; Park Y; Cho NH; Rha SH; Jang JJ; Ro JY; Juhng SW; Choi C
J Korean Med Sci; 2007 Apr; 22(2):305-10. PubMed ID: 17449941
[TBL] [Abstract][Full Text] [Related]
28. Comparison of accuracy of 14-, 18- and 20-G needles in ex-vivo renal mass biopsy: a prospective, blinded study.
Breda A; Treat EG; Haft-Candell L; Leppert JT; Harper JD; Said J; Raman S; Smith RB; Belldegrun AS; Schulam PG
BJU Int; 2010 Apr; 105(7):940-5. PubMed ID: 19888984
[TBL] [Abstract][Full Text] [Related]
29. Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses.
Lee-Felker SA; Felker ER; Tan N; Margolis DJ; Young JR; Sayre J; Raman SS
AJR Am J Roentgenol; 2014 Nov; 203(5):W516-24. PubMed ID: 25341166
[TBL] [Abstract][Full Text] [Related]
30. Exposed proliferation antigen 210 (XPA-210) in renal cell carcinoma (RCC) and oncocytoma: clinical utility and biological implications.
Kruck S; Hennenlotter J; Vogel U; Schilling D; Gakis G; Hevler J; Kuehs U; Stenzl A; Schwentner C
BJU Int; 2012 Feb; 109(4):634-8. PubMed ID: 21711439
[TBL] [Abstract][Full Text] [Related]
31. Exophytic renal masses: angular interface with renal parenchyma for distinguishing benign from malignant lesions at MR imaging.
Verma SK; Mitchell DG; Yang R; Roth CG; O'Kane P; Verma M; Parker L
Radiology; 2010 May; 255(2):501-7. PubMed ID: 20160001
[TBL] [Abstract][Full Text] [Related]
32. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
[TBL] [Abstract][Full Text] [Related]
33. Cathepsin K (Clone EPR19992) Demonstrates Uniformly Positive Immunoreactivity in Renal Oncocytoma, Chromophobe Renal Cell Carcinoma, and Distal Tubules.
Iakymenko OA; Delma KS; Jorda M; Kryvenko ON
Int J Surg Pathol; 2021 Sep; 29(6):600-605. PubMed ID: 33764165
[No Abstract] [Full Text] [Related]
34. Intratumor Heterogeneity of Perfusion and Diffusion in Clear-Cell Renal Cell Carcinoma: Correlation With Tumor Cellularity.
Yuan Q; Kapur P; Zhang Y; Xi Y; Carvo I; Signoretti S; Dimitrov IE; Cadeddu JA; Margulis V; Brugarolas J; Madhuranthakam AJ; Pedrosa I
Clin Genitourin Cancer; 2016 Dec; 14(6):e585-e594. PubMed ID: 27209349
[TBL] [Abstract][Full Text] [Related]
35. Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging.
Taouli B; Thakur RK; Mannelli L; Babb JS; Kim S; Hecht EM; Lee VS; Israel GM
Radiology; 2009 May; 251(2):398-407. PubMed ID: 19276322
[TBL] [Abstract][Full Text] [Related]
36. Renal cell tumors with an entrapped papillary component: a collision with predilection for oncocytic tumors.
Williamson SR; Cheng L; Gadde R; Giannico GA; Wasco MJ; Taylor Smith PJ; Gupta NS; Grignon DJ; Jorda M; Kryvenko ON
Virchows Arch; 2020 Mar; 476(3):399-407. PubMed ID: 31444626
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic accuracy of segmental enhancement inversion for the diagnosis of renal oncocytoma using biphasic computed tomography (CT) and multiphase contrast-enhanced magnetic resonance imaging (MRI).
Schieda N; Al-Subhi M; Flood TA; El-Khodary M; McInnes MD
Eur Radiol; 2014 Nov; 24(11):2787-94. PubMed ID: 25027841
[TBL] [Abstract][Full Text] [Related]
38. A case of oncocytic papillary renal cell carcinoma.
Okada A; Sasaki S; Fujiyoshi Y; Niimi K; Kurokawa S; Umemoto Y; Kohri K
Int J Urol; 2009 Sep; 16(9):765-7. PubMed ID: 19769658
[TBL] [Abstract][Full Text] [Related]
39. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
Halefoglu AM; Ozagari AA
Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
[TBL] [Abstract][Full Text] [Related]
40. Expanding the morphologic spectrum of chromophobe renal cell carcinoma: A study of 8 cases with papillary architecture.
Michalova K; Tretiakova M; Pivovarcikova K; Alaghehbandan R; Perez Montiel D; Ulamec M; Osunkoya A; Trpkov K; Yuan G; Grossmann P; Sperga M; Ferak I; Rogala J; Mareckova J; Pitra T; Kolar J; Michal M; Hes O
Ann Diagn Pathol; 2020 Feb; 44():151448. PubMed ID: 31918172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]